Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1201–1224 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Coronary Disease
Interventions: Cannon Aquilion ONE CT system; Device
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Frozen Embryo Pregnancy Rate
Interventions: Progesterone Vaginal Suppositories, Intramuscular Progesterone-in-Oil; Drug
Lead sponsor: Charles Coddington; Other
Eligibility: 20 Years to 50 Years · Female only
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Contraception
Interventions: FemBloc; Device
Lead sponsor: Femasys Inc.; Industry
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 6
States / cities: Chandler, Arizona • Phoenix, Arizona • Columbus, Georgia + 3 more

Conditions: Osteoarthritis of the Knee
Interventions: 4 mL injection of Ampion, 4 mL injection of Placebo; Biological · Drug
Lead sponsor: Ampio Pharmaceuticals. Inc.; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Brain Cancer
Interventions: Whole Brain Radiation Therapy, Observation, Questionnaire; Procedure · Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Toxoplasmosis, Cerebral, HIV Infections
Interventions: Pyrimethamine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1992
U.S. locations: 16
States / cities: San Francisco, California • Denver, Colorado • New Haven, Connecticut + 11 more

Conditions: Pain, Postoperative
Interventions: IV acetaminophen, oral acetaminophen; Drug
Lead sponsor: Babiash, Kimberly H., M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Wichita, Kansas

Conditions: Exudative Age-related Macular Degeneration
Interventions: 24GyE proton and Anti-VEGF, 16GyE and anti-VEGF, Sham Irradiation and anti-VEGF; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 50 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Hepatic Steatosis, Liver Disease Parenchymal
Interventions: Quantitative ultrasound (DeepUSFF); Device
Lead sponsor: Seoul National University Hospital; Other
Eligibility: 18 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boardman, Ohio

Conditions: Foot Injuries, Ankle Injuries
Interventions: New durable medical equipment (DME) walking boot, Re-used durable medical equipment (DME) walking boot; Device
Lead sponsor: University of Utah; Other
Eligibility: 1 Year to 17 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Congenital Heart Disease, Aortic Valve Stenosis, Fetal Cardiac Disorder, Hypoplastic Left Heart Syndrome
Interventions: Fetal aortic balloon dilatation; Procedure
Lead sponsor: Queen Silvia Children's Hospital, Gothenburg, Sweden; Other
Eligibility: 23 Weeks to 31 Weeks
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 2
States / cities: San Francisco, California • Columbus, Ohio

Conditions: Sexual Wellness, Women Health
Interventions: Shatavari (Asparagus racemosus) Root Extract, Placebo Capsule; Dietary Supplement · Other
Lead sponsor: SF Research Institute, Inc.; Network
Eligibility: 20 Years to 50 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Barrett's Esophagus With Dysplasia
Interventions: Mucosal Impedance, Research Biopsies, Volumetric Laser Endomicroscopy; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: Rochester, Minnesota • New York, New York

Conditions: Corneal Edema, Corneal Endothelial Dysfunction
Interventions: AURN001, Corneal Endothelial Cells, Y27632; Combination Product · Biological · Drug
Lead sponsor: Aurion Biotech; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 17
States / cities: Little Rock, Arkansas • Los Angeles, California • San Francisco, California + 13 more

Conditions: Traumatic Brain Injury
Interventions: N-Acetyl cysteine; Drug
Lead sponsor: HonorHealth Research Institute; Other
Eligibility: 60 Years to 100 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Phoenix, Arizona

Conditions: Type 1 Diabetes
Interventions: 530G Insulin pump; Device
Lead sponsor: Medtronic MiniMed, Inc.; Industry
Eligibility: 2 Years to 15 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 16
States / cities: Los Angeles, California • Orange, California • Sacramento, California + 12 more

Conditions: Postoperative Thromboembolism
Interventions: tumescent lidocaine infiltration; Drug
Lead sponsor: Klein, Jeffrey A., M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: San Juan Capistrano, California

Conditions: Rib Fractures
Interventions: Saline infusion, Lidocaine infusion; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Stanford, California

Conditions: Osteoarthritis, Hip, Rheumatoid Arthritis, Avascular Necrosis
Interventions: Not listed
Lead sponsor: Biomet Orthopedics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 4
States / cities: Chicago, Illinois • Pittsburgh, Pennsylvania • Fredericksburg, Virginia + 1 more

Conditions: Cataract, Glaucoma, Ocular Hypertension
Interventions: Bimatoprost Implant System (High Dose), Bimatoprost Implant System (Low Dose), Timolol Maleate Ophthalmic Solution, 0.5%, Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOL, SpyGlass IOL; Drug · Device
Lead sponsor: SpyGlass Pharma, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Glendale, Arizona

Conditions: Uterine Fibroids, Uterine Artery Embolization
Interventions: pregabalin/celecoxib, pregabalin/placebo, celecoxib/placebo, Placebo group; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Dry Eye
Interventions: DE-101 ophthalmic suspension, DE-101 ophthalmic suspension vehicle; Drug
Lead sponsor: Santen Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 10
States / cities: Inglewood, California • Torrance, California • Bloomfield, Connecticut + 7 more

Conditions: Partial Edentulism, Tooth Disease
Interventions: Dental implant Osseotite Prevail, Dental implant Osseotite; Device
Lead sponsor: ZimVie; Industry
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Reproductive Sterilization
Interventions: Adiana Transcervical Sterilization System; Device
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 770 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2013
U.S. locations: 14
States / cities: Phoenix, Arizona • Roseville, California • San Rafael, California + 11 more

Search by objective public record fields.

Evaluating New Radiation Techniques for Cardiovascular Imaging

Progesterone Support of FET

FemBloc® Permanent Contraception - Confirmation Feasibility Trial

A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain

Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy

A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection

Equality Study of Ofirmev vs Oral Acetaminophen

ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)

Quantitative Ultrasound (RS85 and R20) for Liver Fat Quantification in MASLD Using MRI-PDFF as Reference

The Safety of Reusing Walking Boot Components for Patients Recovering From Acute Foot and Ankle Injuries

Effect of Fetal Aortic Valvuloplasty on Outcomes

Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness

Characterization of the Neo-squamous Epithelial Barrier

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients

Threshold Suspend in Pediatrics at Home

Effect of Tumescent Lidocaine on Platelet Function

Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia

A Clinical Investigation of the Balance® Microplasty™ Hip System

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution

Preemptive Analgesia Following Uterine Artery Embolization

Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients

A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.

Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Sterilization)